0001144204-14-002531.txt : 20140116
0001144204-14-002531.hdr.sgml : 20140116
20140116133345
ACCESSION NUMBER: 0001144204-14-002531
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140116
DATE AS OF CHANGE: 20140116
EFFECTIVENESS DATE: 20140116
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI SCIENCE, INC.
CENTRAL INDEX KEY: 0001431739
IRS NUMBER: 261334146
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-210257
FILM NUMBER: 14531561
BUSINESS ADDRESS:
STREET 1: 2430 PALUMBO DRIVE
STREET 2: SUITE 140
CITY: LEXINGTON
STATE: KY
ZIP: 40509
BUSINESS PHONE: 859-266-9200
MAIL ADDRESS:
STREET 1: 2430 PALUMBO DRIVE
STREET 2: SUITE 140
CITY: LEXINGTON
STATE: KY
ZIP: 40509
FORMER COMPANY:
FORMER CONFORMED NAME: CTI SCIENCE INC
DATE OF NAME CHANGE: 20080407
D
1
primary_doc.xml
X0707
D
LIVE
0001431739
CTI SCIENCE, INC.
2430 PALUMBO DRIVE
SUITE 140
LEXINGTON
KY
KENTUCKY
40509-1117
(859) 266-9200
DELAWARE
Chelator Technologies, Inc.
CTI SCIENCE INC
Corporation
true
BOYD
E.
HALEY
2430 PALUMBO DRIVE
SUITE 140
LEXINGTON
KY
KENTUCKY
40509-1117
Executive Officer
Director
Promoter
J.
TODD
RENNER
2430 PALUMBO DRIVE
SUITE 140
LEXINGTON
KY
KENTUCKY
40509-1117
Executive Officer
Director
KATHRYN
M.
WACHSMAN
55 WALL STREET
SUITE 838
NEW YORK
NY
NEW YORK
10005
Executive Officer
Director
RAGNAR
KLINGBERG
BRANTINGSGATAN 42, 2TR
STOCKHOLM
V7
SWEDEN
11535
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2013-12-04
true
true
true
false
0
5000000
271000
4729000
false
4
0
0
0
false
CTI SCIENCE, INC.
/s/ J. Todd Renner
J. Todd Renner
CHIEF FINANCIAL OFFICER
2014-01-16